Abstract Body

We conducted an analysis to determine if differences in health-seeking behaviour may explain gender disparities in mortality among long-term survivors receiving antiretroviral therapy (ART) in rural Uganda.

From June 2012 to September 2013, we enrolled patients receiving a first-line ART regimen for at least four years without previous viral load (VL) testing in Jinja, Uganda. We measured HIV VL at study entry. We switched participants to second-line therapy, if VL was ≥1000 copies/mL on two measurements, and followed all participants for three years. We collected clinical and behavioral data at enrollment and every six months. We used Cox proportional hazards modeling to examine factors associated with hospitalization and mortality until September 2016.

We enrolled 616 participants or whom 75.3% were female. The median age was 44 years (interquartile range [IQR]39-50 years), the median duration of ART was 6 years (IQR 5-7 years) and the median CD4 count at enrollment was 523 cells/µL (IQR 362- 707). Of these, 113 (18.3%) had VLs≥1000 copies/mL at enrollment.  Participants were followed for a median of 2.8 years (IQR 2.6-3.2) years during which hospitalizations occurred in 101 participants (7% of men vs. 20% of women; p<0.001). A total of 22 (3.6%) deaths occurred; 9% of men vs. 2% of women (p <0.001). Participants who were hospitalized had a lower risk of mortality in the univariate analysis (HR=0.22; 95% CI 0.03-1.63), but it was not statistically significant (p=0.138) and was not included in the final model.  In the multivariate model, mortality was associated with age (adjusted hazard ratio (AHR) = 1.07 per year increase; 95% CI 1.01-1. 13), male gender (AHR = 2.57; 95% CI 1.06-6.23) and time-updated CD4 counts (AHR = 0.67 per 100 cell increment; 95% CI 0.52-0.88). Virologic failure at enrollment was not associated with mortality (AHR = 1.18; 95% CI 0.40 – 3.47).

Female patients receiving ART for more than 6 years in rural Uganda were three times more likely to be hospitalized than men, but male mortality was nearly four times higher in the subsequent three years of follow-up. Facilitating care for acute medical problems may help to improve survival among male ART patients.